MWG Management Ltd.

Est. AUM

$81.3M

13F long equity, this entity only

Positions

Period

Sep 2025 (Q3)

SEC EDGAR

Sep 2025 (Q3)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	BEAM THERAPEUTICS INC	COM	$55.0M	2266934	67.66%	DFND
2	LYELL IMMUNOPHARMA INC	COM NEW	$16.4M	1008116	20.13%	DFND
3	PRIME MEDICINE INC	COM	$9.9M	1792210	12.21%	DFND

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.